Serum Institute of India Partners with Oxford University to Develop Meningitis-B Vaccine

▴ Develop Meningitis-B Vaccine
The licensing agreement between Serum Institute of India and Oxford University represents a significant step forward in the fight against Meningitis-B.

In a significant development for global health, Serum Institute of India Pvt. Ltd. Has announced a ground-breaking licensing agreement with the University of Oxford to manufacture and distribute a chimeric protein-based vaccine targeting Meningitis-B. This collaboration, spanning five years, aims to combat a severe infection that poses risks to the brain and spinal cord.

Serum Institute’s Commitment to Global Health: Adar Poonawalla, CEO of Serum Institute, emphasized the importance of accessible vaccines in the fight against diseases and expressed commitment to global health. He highlighted the partnership as a shared dedication to improving health outcomes worldwide, especially in regions vulnerable to meningitis outbreaks.

“This collaboration exemplifies a shared dedication to global health and underscores the importance of accessible vaccines,” said Adar Poonawalla. “Our goal is to ensure life-saving protection reaches those who need it most.”

Milestone for Vaccine Innovation: The licensing agreement with Oxford University marks a significant milestone in vaccine innovation. Simon Warner, Head of Licensing & Ventures – Life Sciences at Oxford University Innovation, praised the agreement as a testament to Oxford’s commitment to developing effective vaccines.

“The Men-B vaccine agreement with the Serum Institute of India is another example of vaccine innovation at the University of Oxford,” said Simon Warner. “Oxford’s investment in developing deployable vaccines will protect millions of lives, and academic licensing and successful commercial partnerships play a crucial role in addressing global health challenges.”

Serum Institute’s Role in Combating Meningitis: Serum Institute’s collaboration with Oxford University builds on its success with the MenFive vaccine, which received pre-qualification from the World Health Organization in July 2023. This achievement solidified Serum Institute’s role as a key player in combating meningitis outbreaks on a global scale.
The partnership between Serum Institute and Oxford University reflects a shared commitment to advancing vaccine research and accessibility. By utilising academic expertise and industry experience, the collaboration aims to develop and distribute life-saving vaccines to populations in need. As Serum Institute continues to expand its portfolio of vaccines, including efforts to combat meningitis, the company reaffirms its dedication to improving global health outcomes and addressing pressing public health challenges.

The licensing agreement between Serum Institute of India and Oxford University represents a significant step forward in the fight against Meningitis-B. By combining scientific expertise and resources, the collaboration aims to develop and distribute an effective vaccine that will protect vulnerable populations worldwide. This partnership showcases the importance of innovation and collaboration in addressing global health challenges and improving access to life-saving vaccines.

Tags : #

About the Author

Sunny Parayan

Hey there! I'm Sunny, a passionate writer with a strong interest in the healthcare domain! When I'm not typing on my keyboard, I watch shows and listen to music. I hope that through my work, I can make a positive impact on people's lives by helping them live happier and healthier.

View Profile

Related Stories

Loading Please wait...


Trending Now

The Dangers of Ultra-Processed Foods: A Wake-Up Call for Health Conscious IndiansMay 23, 2024
Can Intermittent Fasting Protect Against Liver Cancer? Here’s What the Science SaysMay 23, 2024
Easier, Faster Claims: The Impact of the National Claim Exchange PortalMay 23, 2024
Can Nightmares Predict Autoimmune Flares? Insights from a Groundbreaking StudyMay 23, 2024
Does Parent-Led Singing Improve Development in Preterm Infants? A Comprehensive StudyMay 22, 2024
Biohacking 101: Boosting Physical and Mental Well-beingMay 22, 2024
In a Miraculous Recovery a 13-Year-Old Girl in Delhi Awakens from Coma After Liver Transplant.May 21, 2024
Tackling Hypertension in South-East Asia: A Call to Action on World Hypertension DayMay 20, 2024
FSSAI's Crackdown on Harmful Fruit Ripening Practices: Ensuring Public Health and ComplianceMay 20, 2024
Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024